Aptamer Technologies Market to Exceed $11.2 Billion by 2032 with 17.4% CAGR Expansion
The global Aptamer Technologies market is witnessing substantial growth due to rising investments in precision medicine, molecular diagnostics, and targeted therapeutics. In 2023, the market was valued at approximately $2.9 billion, and it is projected to grow at a CAGR of 17.4% from 2024 to 2032. Increasing adoption in drug discovery and biosensor applications has driven annual demand growth by over 21% since 2020.
Read Full Research Study: